BROWSE·page 543 of 604

Browse EX-10 agreements

7,247 matching material contract exhibits.


EX-10.3

Imunon, Inc.

Exhibit 10.3

SECURED PROMISSORY NOTE B

Effective Date: June 2, 2026 U.S. $5,000,000.00

FOR VALUE RECEIVED, Imunon, Inc., a Delaware corporation (“Borrower”), promises to pay to Streeterville Capital, LLC, a Utah limited liability company, or its successors or assigns (“Lender”), $5,000,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is eighteen (18) months after the Purchase Price Date (the “Maturity Date”) in accordance with the terms set forth herein and to pay interest on the Outstanding Balance at the rate of five percent (5%) per annum from the Purchase Price Date until the same is paid in full. All interest calculations hereunder shall be computed on the basis of a 360-day year comprised of twelve (12) thirty (30) day months, shall compound daily and shall be payable in accordance with the terms of this Note. This Secured Promissory Note B (this “Note”) is issued and made effective as of June 2, 2026 (the “Effective Date”).

…

EX-10.3·8-K·CIK 749647·ACC 0001493152-26-027201·Filed Jun 04, 2026, 08:00 ET

EX-10.2

Imunon, Inc.

SECURED PROMISSORY NOTE A-1

Effective Date: June 2, 2026 U.S. $2,720,000.00

FOR VALUE RECEIVED, Imunon, Inc., a Delaware corporation (“Borrower”), promises to pay to Streeterville Capital, LLC, a Utah limited liability company, or its successors or assigns (“Lender”), $2,720,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is eighteen (18) months after the Purchase Price Date (the “Maturity Date”) in accordance with the terms set forth herein and to pay interest on the Outstanding Balance at the rate of eight percent (8%) per annum from the Purchase Price Date until the same is paid in full. All interest calculations hereunder shall be computed on the basis of a 360-day year comprised of twelve (12) thirty (30) day months, shall compound daily and shall be payable in accordance with the terms of this Note. This Secured Promissory Note A-1 (this “Note”) is issued and made effective as of June 2, 2026 (the “Effective Date”).

…

EX-10.2·8-K·CIK 749647·ACC 0001493152-26-027201·Filed Jun 04, 2026, 08:00 ET

EX-10.1

Imunon, Inc.

Securities Purchase Agreement

This Securities Purchase Agreement (this “Agreement”), dated as of June 2, 2026, is entered into by and between Imunon, Inc., a Delaware corporation (“Company”), and Streeterville Capital, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).

A. Company and Investor are executing and delivering this Agreement in reliance upon Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”).

…

EX-10.1·8-K·CIK 749647·ACC 0001493152-26-027201·Filed Jun 04, 2026, 08:00 ET

EX-10.1

CONMED Corp

PURCHASE AGREEMENT

June 3, 2026

[●] (the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (the “Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is selling Outstanding Notes (as defined below), referred to hereunder as a “Holder”), enters into this Purchase Agreement (this “Agreement”) with CONMED Corporation, a Delaware corporation (the “Company”), as of the date first written above, pursuant to which the Company will purchase from each Holder the Outstanding Notes held by each Holder and specified on Exhibit A hereto for an amount in cash equal to the Cash Consideration (as defined in Exhibit A hereto).

On and subject to the terms and conditions set forth in this Agreement, the parties hereto agree as follows:

Article I: Purchase of the Existing Notes

…

EX-10.1·8-K·CIK 816956·ACC 0001174947-26-000639·Filed Jun 04, 2026, 07:30 ET

EX-10.1

Syndax Pharmaceuticals Inc

June 3, 2026

Syndax Pharmaceuticals, Inc.

730 Third Avenue, 9th Floor

New York, New York

Attention: General Counsel and Chief Financial Officer

Re: Subscription for Syndax Pharmaceuticals, Inc. Convertible Senior Notes due 2031

Ladies and Gentlemen:

Syndax Pharmaceuticals, Inc., a Delaware corporation, (the “Company”), is offering a new series of its Convertible Senior Notes due 2031 (the “Notes”). The Notes will be convertible into cash, shares (“Underlying Shares”) of common stock of the Company, par value $0.0001 per share (“Stock”), or a combination of cash and Underlying Shares, at the Company’s election, in accordance with the terms of the Indenture (as defined below).

…

EX-10.1·8-K·CIK 1395937·ACC 0001193125-26-256458·Filed Jun 04, 2026, 07:16 ET

EX-10.3

Trulieve Cannabis Corp.

PROTECTION AGREEMENT HARVEST ENTERPRISES HOLDINGS, INC. - and - TRULIEVE CANNABIS CORP. - and - HARVEST ENTERPRISES, LLC. June 2, 2026


TABLE OF CONTENTS 1. DEFINITIONS. ...............................................................................................................................3 2. CONDUCT OF BUSINESS OF THE COMPANY......................................................................8 (a) Conduct ................................................................................................................................8 (b) Restrictions ..........................................................................................................................8 (c) Obligations.........................................................................................................................10 (d) Notices................................................................................................................................10 (e) Updates ...............................................................................................................

…

EX-10.3·8-K·CIK 1754195·ACC 0001754195-26-000033·Filed Jun 04, 2026, 06:42 ET

EX-10.1

Trulieve Cannabis Corp.

LIMITED LIABILITY COMPANY AGREEMENT Harvest Enterprises, LLC (A Delaware Limited Liability Company) Effective as of June 2, 2026 THE LIMITED LIABILITY COMPANY INTERESTS REPRESENTED BY THIS LIMITED LIABILITY COMPANY AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE STATE SECURITIES LAWS OF ANY STATE. WITHOUT SUCH REGISTRATION, SUCH MEMBERSHIP INTERESTS MAY NOT BE SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED AT ANY TIME WHATSOEVER, EXCEPT UPON DELIVERY TO THE COMPANY OF AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED FOR SUCH TRANSFER AND/OR SUBMISSION TO THE COMPANY OF SUCH OTHER EVIDENCE AS MAY BE SATISFACTORY TO THE COMPANY TO THE EFFECT THAT ANY SUCH TRANSFER WILL NOT BE IN VIOLATION OF THE SECURITIES ACT OF 1933, AS AMENDED, AND/OR APPLICABLE STATE SECURITIES LAWS AND/OR ANY RULE OR REGULATION PROMULGATED THEREUNDER.


…

EX-10.1·8-K·CIK 1754195·ACC 0001754195-26-000033·Filed Jun 04, 2026, 06:42 ET

EX-10.2

Trulieve Cannabis Corp.

CLASS A UNIT PURCHASE AGREEMENT THIS CLASS A UNIT PURCHASE AGREEMENT (this “Agreement”), is made as of June 2, 2026 by and among Harvest Enterprises, LLC (the “Company”) and Whitley Holding 05192026, LLC (the “Purchasers”), and solely for the purposes of Sections 6.2 and 6.3, Trulieve Cannabis Corp, a corporation existing under the laws of the Province of British Columbia, Canada (“Trulieve”). The parties hereby agree as follows: 1. Purchase and Sale of Preferred Units. 1.1 Sale and Issuance of Class A Units. Subject to the terms and conditions of this Agreement, the Purchasers agree to purchase at the Closing and the Company agrees to sell and issue to the Purchasers at the Closing the number of Class A Units (the “Class A Units”) set forth opposite each Purchaser’s name on Schedule 1. The Class A Units issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the “Units.” 1.2 Closing; Delivery. The purchase and sale of the Units shall take place as of the date of this Agreement remotely via electronic exchange of signature pages (the “Closing”).

…

EX-10.2·8-K·CIK 1754195·ACC 0001754195-26-000033·Filed Jun 04, 2026, 06:42 ET

EX-10.1

MARSH & MCLENNAN COMPANIES, INC.

EXECUTION VERSION [[8499770]] US$4,250,000,000 AMENDED AND RESTATED 5 YEAR CREDIT AGREEMENT dated as of June 2, 2026 Among Marsh & McLennan Companies, Inc. Calm Treasury Holdings Limited, MMC Securities LLC, and the Designated Subsidiaries referred to herein as Borrowers, The Lenders Listed Herein and Citibank, N.A. as Administrative Agent Bank of America, N.A., Deutsche Bank Securities Inc. HSBC Bank USA, National Association JPMorgan Chase Bank, N.A. and Wells Fargo Bank, National Association as Syndication Agents Barclays Bank PLC, Morgan Stanley MUFG Loan Partners, LLC, PNC Bank, National Association, The Toronto-Dominion Bank, New York Branch, The Bank of Nova Scotia, and Royal Bank of Canada as Documentation Agents Citibank, N.A., BofA Securities, Inc., Deutsche Bank Securities Inc. and HSBC Securities (USA) Inc. JPMorgan Chase Bank, N.A. and Wells Fargo Securities, LLC as Joint Lead Arrangers and Joint Bookrunners


…

EX-10.1·8-K·CIK 62709·ACC 0000062709-26-000167·Filed Jun 03, 2026, 17:32 ET

EX-10.1

OUTFRONT Media Inc.

OUTFRONT MEDIA INC.

OMNIBUS STOCK INCENTIVE PLAN

(AS AMENDED AND RESTATED AS OF JUNE 3, 2026)

ARTICLE I

GENERAL

Section 1.1 Purpose.

The purpose of the OUTFRONT Media Inc. Omnibus Stock Incentive Plan (as amended and restated as of June 3, 2026) (the “Plan”) is to benefit and advance the interests of OUTFRONT Media Inc., a Maryland corporation (the “Company”), and its Subsidiaries (as defined below) by attracting, retaining and motivating Participants (as defined below) and to compensate Participants for their contributions to the financial success of the Company and its Subsidiaries.

Section 1.2 Definitions.

As used in the Plan, the following terms shall have the following meanings:

(a) “Administrator” shall mean the individual or individuals to whom the Committee delegates authority under the Plan in accordance with Section 1.3 hereof.

(b) “Affiliate” means a corporation or other entity controlled by, controlling or under common control with the Company.

…

EX-10.1·8-K·CIK 1579877·ACC 0001579877-26-000024·Filed Jun 03, 2026, 17:22 ET

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of June 1, 2026, between LightPath Technologies, Inc., a Delaware corporation (the “Company”), North Run Strategic Opportunities Fund I, LP (the “Selling Stockholder”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to effective registration statements under the Securities Act (as defined below), the Company and the Selling Stockholder desire to issue and sell, as applicable, to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company the Selling Stockholder, securities of the Company as more fully described in this Agreement.

…

EX-10.1·8-K·CIK 889971·ACC 0001437749-26-019435·Filed Jun 03, 2026, 17:20 ET

EXHIBIT 10.2 PLACEMENT AGENCY AGREEMENT

LIGHTPATH TECHNOLOGIES INC

PLACEMENT AGENCY AGREEMENT

June 1, 2026

Craig-Hallum Capital Group LLC

323 N Washington Ave., Suite 300

Minneapolis, MN 55401

Ladies and Gentlemen:

Introduction. Subject to the terms and conditions herein (this “Agreement”), LightPath Technologies, Inc., a Delaware corporation (the “Company”), and North Run Strategic Opportunities Fund I, LP (together with its affiliates, the “Selling Stockholder”), hereby agree to sell up to an aggregate of $100.0 million of registered securities of the Company, including, but not limited to, 7,142,800 shares (the “Shares”) of the Company’s Class A common stock, $0.01 par value per share (the “Common Stock”), of which 3,571,400 Shares are being sold by the Company and 3,571,400 Shares are being sold by the Selling Stockholder, directly to various investors (each, an “Investor” and, collectively, the “Investors”) through Craig-Hallum Capital Group LLC (the “Placement Agent”) as placement agent. The documents executed and delivered by the Company, the Selling Stockholder and the Investors in connection with the Offering (as defined b

…

EX-10.2·8-K·CIK 889971·ACC 0001437749-26-019435·Filed Jun 03, 2026, 17:20 ET